CTCF genetic alterations in endometrial carcinoma are pro-tumorigenic

LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma

(2016) Amy D. Marshall et al.   INTERNATIONAL JOURNAL OF CANCER

Patterns ofCTCFandZFHX3Mutation and Associated Outcomes in Endometrial Cancer

(2015) Christopher J. Walker et al.   JNCI-Journal of the National Cancer Institute

Intron retention is a widespread mechanism of tumor-suppressor inactivation

(2015) Hyunchul Jung et al.   NATURE GENETICS

Patterns ofCTCFandZFHX3Mutation and Associated Outcomes in Endometrial Cancer

(2015) Christopher J. Walker et al.   JNCI-Journal of the National Cancer Institute

CTCF Haploinsufficiency Destabilizes DNA Methylation and Predisposes to Cancer

(2014) Christopher J. Kemp et al.   Cell Reports

Orchestrated Intron Retention Regulates Normal Granulocyte Differentiation

(2013) Justin J.-L. Wong et al.   CELL

CTCF and BORIS in genome regulation and cancer

(2013) Amy D Marshall et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

High Frequency Strand Slippage Mutations inCTCFin MSI-Positive Endometrial Cancers

(2013) Israel Zighelboim et al.   HUMAN MUTATION

The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells

(2013) Jessamy C. Tiffen et al.   INTERNATIONAL JOURNAL OF CANCER

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

Mutational landscape and significance across 12 major cancer types

(2013) Cyriac Kandoth et al.   NATURE

The landscape of somatic mutations in Down syndrome–related myeloid disorders

(2013) Kenichi Yoshida et al.   NATURE GENETICS

A Genome-wide Map of CTCF Multivalency Redefines the CTCF Code

(2013) Hirotaka Nakahashi et al.   Cell Reports

Quantitative assessment of higher-order chromatin structure of the INK4/ARF locus in human senescent cells

(2012) Akiyuki Hirosue et al.   AGING CELL

Cdh1 Is Essential for Endometrial Differentiation, Gland Development, and Adult Function in the Mouse Uterus1

(2012) Sarah N. Reardon et al.   BIOLOGY OF REPRODUCTION

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

(2012) Matthieu Le Gallo et al.   NATURE GENETICS

Loss of Maternal CTCF Is Associated with Peri-Implantation Lethality of Ctcf Null Embryos

(2012) James M. Moore et al.   PLoS One

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Epithelial cell polarity: a major gatekeeper against cancer?

(2011) C Royer et al.   CELL DEATH AND DIFFERENTIATION

Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms

(2011) Y.-H. Cheng et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

(2011) Marta Llauradó et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

CREBBP mutations in relapsed acute lymphoblastic leukaemia

(2011) Charles G. Mullighan et al.   NATURE

Risk factors in women 40 years of age and younger with endometrial carcinoma

(2010) Dimitrios Haidopoulos et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA

A Novel Three-Dimensional Culture System of Polarized Epithelial Cells to Study Endometrial Carcinogenesis

(2010) Núria Eritja et al.   AMERICAN JOURNAL OF PATHOLOGY

DNA methylation prevents CTCF-mediated silencing of the oncogeneBCL6in B cell lymphomas

(2010) Anne Y. Lai et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines

(2010) E Soto-Reyes et al.   ONCOGENE

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists

(2009) Eran Eden et al.   BMC BIOINFORMATICS

CTCF: Master Weaver of the Genome

(2009) Jennifer E. Phillips et al.   CELL

Dicer1 functions as a haploinsufficient tumor suppressor

(2009) M. S. Kumar et al.   GENES & DEVELOPMENT

Endometrial hyperplasia and the risk of progression to carcinoma

(2009) James V. Lacey et al.   MATURITAS

Epigenetic Silencing of the p16INK4a Tumor Suppressor Is Associated with Loss of CTCF Binding and a Chromatin Boundary

(2009) Michael Witcher et al.   MOLECULAR CELL

Diagnosing Endometrial Hyperplasia

(2008) Kimberly H. Allison et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Transcriptional regulation of cell polarity in EMT and cancer

(2008) G Moreno-Bueno et al.   ONCOGENE

Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats

(2008) M. J. Herold et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA